Accumulating evidence indicates HTR2A engages pro-hypertrophic signalling via the PI3K–PDK1–AKT–mTOR pathway in an isoproterenol (ISO)–induced mouse model of cardiac hypertrophy [56]. The gene discussed is AKT1; the disease is cardiac hypertrophy.